Your browser doesn't support javascript.
loading
Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis.
Chen, Y C; Peng, C Y; Jeng, W J; Chien, R N; Liaw, Y F.
Afiliação
  • Chen YC; Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
  • Peng CY; School of Medicine, Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
  • Jeng WJ; Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
  • Chien RN; Liver Research Unit, Chang Gung Memorial Hospital and University, Keelung, Taiwan.
  • Liaw YF; Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Aliment Pharmacol Ther ; 42(10): 1182-91, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26381928

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Carcinoma Hepatocelular / Hepatite B Crônica / Guanina Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Carcinoma Hepatocelular / Hepatite B Crônica / Guanina Idioma: En Ano de publicação: 2015 Tipo de documento: Article